Scentre Group Ltd looks expensive for dividend shoppers

Scentre Group Ltd (ASX:SCG) shares look expensive.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This morning the operator of the Westfield shopping centres across Australia and New Zealand, Scentre Group Ltd (ASX: SCG), reported a funds from operations profit of $617 million for the six-month period ending June 30 2016. That represents 11.61 cents per security and a dividend distribution of 10.65 cents per security.

The Westfield Group will need no introduction to Australians thanks to its plethora of giant shopping centres in prime locations across major Australian cities. In fact some of these shopping centres are so large they deserve their own postcode, with a recent deal announced to expand the size of its Westfield Sydney shopping centre even further. The expansion involves the acquisition of the adjacent David Jones building which will provide an additional 10,000 square metres of retail space.

The Scentre Group is firmly focused on only owning the most profitable assets in prime locations as the popularity of the assets among consumers and retailers is ultimately what determines the ability to lift rents. Traditionally rents have been lifted by contracted amounts above core inflation, with a forecast for a lift in net property income of 2.5%-3% for the full financial year.

Tenant demand is unsurprisingly strong and the key challenge for investors is valuation as the group trades on a big premium to the value of its net tangible assets as a result of the global yield-hunt in today's ultra-low cash rate world.

The group expects to deliver a full year distribution of 21.3 cents per security, which places it on a yield of 4.2% with the shares at $5.09 today. Despite the quality of the business the shares look overvalued and vulnerable to a correction if we have witnessed the bottom of the global cash rate cycle.

Motley Fool contributor Tom Richardson has no position in any stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »